Figure 3.
Use of optimal medical therapy (OMT) (aspirin or thienopyridine, β-blockers and statins) in the overall population and in the two groups of patients and OMT (aspirin or thienopyridine, β-blockers, statins and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) among eligible patients.